Trial Profile
Phase I Study of Cabazitaxel - Platinum Fluorouracil Induction Chemotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 May 2018
Price :
$35
*
At a glance
- Drugs Cabazitaxel (Primary) ; Cisplatin; Fluorouracil
- Indications Head and neck cancer; Squamous cell cancer
- Focus Adverse reactions
- 02 Jun 2015 Results of dose escalation phase are presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 09 Feb 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 28 Jun 2011 New trial record